ForMED Ventures

Aqua Medical, Inc. is a medical technology company that specializes in developing vapor-based, endoscopic ablation systems aimed at treating gastrointestinal diseases and preventing gastrointestinal cancers. Founded in 2016 by Virender K. Sharma, the company is headquartered in Santa Ana, California. Its innovative ablation technology utilizes high-temperature water vapor generated by a radiofrequency generator, which is delivered endoscopically through proprietary catheters to various parts of the gastrointestinal tract. This platform enables medical practitioners to perform effective, non-surgical treatments for conditions such as pancreatic cysts and esophageal issues, offering a convenient and efficient alternative to traditional surgical methods.

Eximis Surgical is a medical device company based in Louisville, Colorado, founded in 2014. The company specializes in developing innovative technologies for specimen removal in laparoscopic surgery. Its primary device utilizes RF energized cutting wires housed within a containment bag, allowing surgeons to efficiently remove large specimens through small incisions. This technology integrates seamlessly into existing surgical protocols, significantly reducing the time required for specimen removal to just minutes. Additionally, it minimizes patient discomfort and enhances safety by separating specimens into narrow strips, thereby facilitating clean tissue segmentation for pathology identification. Eximis Surgical's focus on enabling minimally invasive surgical procedures aims to improve patient outcomes and streamline the surgical process.

Advanced NanoTherapies, Inc. is a biotechnology company focused on developing innovative medical devices utilizing Sirolimus and biodegradable functionalized nanoparticle technology for the treatment of atherosclerosis and related conditions, including coronary artery disease and peripheral artery disease. Founded in 2018, the company is headquartered in Cleveland, Ohio. Advanced NanoTherapies aims to enhance drug delivery through its proprietary platform, which improves medication uptake and retention at the cellular level. This technology provides clinicians with safer treatment options for patients suffering from cardiovascular and endovascular diseases.